Medicaid Data Analysis for Bacterial Respiratory Pathogens and Information Systems

The CDC’s Division of Bacterial Diseases is procuring a sole‑source BPA to continue advanced Medicaid data analysis for bacterial respiratory pathogens. Mathematica Inc. will refine infant GBS case‑count validation, enhance mother‑infant linkage algorithms, estimate maternal vaccination coverage, and reduce gestational‑age missingness using privileged CMS Medicaid data. The effort builds on prior CDC contracts, leveraging Mathematica’s “innovator‑status” access and proprietary methodology. • Four technical tasks: (1) GBS case validation, (2) probabilistic mother‑infant linkage, (3) maternal vaccine coverage estimation, (4) gestational‑age data completion. • Base period 27 Sep 2026 – 26 Sep 2027 with up to four one‑year options, potentially extending to 26 Sep 2031. • Estimated BPA value ≈ $5 million; pricing based on GSA Schedule rates (FAR 8.401 sole‑source justification).